Indication
Acne vulgaris
Acne vulgaris is a common, chronic inflammatory dermatologic disorder of the pilosebaceous unit that most frequently affects adolescents and young adults, though it can persist into or develop during adulthood. Read more about Acne vulgaris
800 drugs 238 manufacturers
Drugs that treat it
Common Acne vulgaris therapies.
CLINDAMYCIN PHOSPHATE
DAPSONE
CLINDAMYCIN PHOS-BENZOYL PEROX (clindamycin phosphate/benzoyl peroxide)
CLINDAMYCIN PHOSPHATE
CLINDAMYCIN-BENZOYL PEROXIDE (clindamycin phosphate/benzoyl peroxide)
TRETINOIN
VESTURA (ethinyl estradiol/drospirenone)
ADAPALENE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcne vulgaris is a common, chronic inflammatory dermatologic disorder of the pilosebaceous unit that most frequently affects adolescents and young adults, though it can persist into or develop during adulthood.
Its pathogenesis is driven by an interplay of follicular hyperkeratinization, androgen-mediated sebum overproduction, colonization by the bacterium *Cutibacterium acnes*, and subsequent host immune and inflammatory responses.
Clinically, it manifests primarily on sebum-rich areas such as the face, neck, chest, and back with noninflammatory open and closed comedones, alongside inflammatory papules, pustules, nodules, and cysts.
Left unmanaged, severe or prolonged presentations can result in permanent cutaneous scarring, post-inflammatory hyperpigmentation, and significant psychological distress.
- nih.gov
Acne vulgaris is a common, chronic inflammatory dermatologic disorder of the pilosebaceous unit that most frequently affects adolescents and young adults, though it can persist into or develop during adulthood Clinically, it manifests primarily on sebum-rich areas such as the face, neck, chest, and back with noninflammatory open and closed comedones, alongside inflammatory papules, pustules, nodules, and cysts
- nih.gov
Acne vulgaris is a common, chronic inflammatory dermatologic disorder of the pilosebaceous unit that most frequently affects adolescents and young adults, though it can persist into or develop during adulthood Its pathogenesis is driven by an interplay of follicular hyperkeratinization, androgen-mediated sebum overproduction, colonization by the bacterium *Cutibacterium acnes*, and subsequent host immune and inflammatory responses
- nih.gov
Acne vulgaris is a common, chronic inflammatory dermatologic disorder of the pilosebaceous unit that most frequently affects adolescents and young adults, though it can persist into or develop during adulthood Clinically, it manifests primarily on sebum-rich areas such as the face, neck, chest, and back with noninflammatory open and closed comedones, alongside inflammatory papules, pustules, nodules, and cysts
- nih.gov
Its pathogenesis is driven by an interplay of follicular hyperkeratinization, androgen-mediated sebum overproduction, colonization by the bacterium *Cutibacterium acnes*, and subsequent host immune and inflammatory responses
- nih.gov
Its pathogenesis is driven by an interplay of follicular hyperkeratinization, androgen-mediated sebum overproduction, colonization by the bacterium *Cutibacterium acnes*, and subsequent host immune and inflammatory responses
- medlineplus.gov
Clinically, it manifests primarily on sebum-rich areas such as the face, neck, chest, and back with noninflammatory open and closed comedones, alongside inflammatory papules, pustules, nodules, and cysts
- nih.gov
Left unmanaged, severe or prolonged presentations can result in permanent cutaneous scarring, post-inflammatory hyperpigmentation, and significant psychological distress
Personalize your experience
Follow Acne vulgaris and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.